Blue Trust’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
Blue Trust's COGT Position: Q3 2026 in Review
Blue Trust sold out of Cogent Biosciences (COGT) in Q3 2026, closing a stake of 133 shares — an estimated $5.15K sold.
Blue Trust first reported a position in COGT in Q2 2022 and held it in 4 quarters. The position peaked at $5.15K in Q2 2026. 202 funds tracked by Wall St. Rank hold COGT as of Q3 2026.
- Blue Trust reported no remaining Cogent Biosciences position as of Q3 2026 after selling out during the quarter.
- Blue Trust sold 133 Cogent Biosciences shares in Q3 2026, an estimated $5.15K.
- Blue Trust first reported a position in Cogent Biosciences in Q2 2022 and held it in 4 quarters.
- Blue Trust's Cogent Biosciences position peaked at $5.15K in Q2 2026.
- 202 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.